Cornerstone Investment Partners LLC Has $72.39 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Cornerstone Investment Partners LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 241,163 shares of the company’s stock after acquiring an additional 24,483 shares during the period. HCA Healthcare makes up about 3.6% of Cornerstone Investment Partners LLC’s portfolio, making the stock its 9th largest holding. Cornerstone Investment Partners LLC owned approximately 0.10% of HCA Healthcare worth $72,385,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. First Horizon Advisors Inc. increased its position in HCA Healthcare by 2.4% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after purchasing an additional 36 shares in the last quarter. Mediolanum International Funds Ltd increased its position in HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after acquiring an additional 36 shares during the period. Hartford Funds Management Co LLC increased its position in HCA Healthcare by 1.6% in the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock valued at $1,003,000 after acquiring an additional 39 shares during the period. Prairie Wealth Advisors Inc. boosted its stake in shares of HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock valued at $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Financial Counselors Inc. boosted its stake in shares of HCA Healthcare by 3.0% in the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company’s stock valued at $630,000 after purchasing an additional 45 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on HCA shares. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp reduced their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $311.11 on Tuesday. The firm has a 50-day moving average of $315.30 and a 200-day moving average of $348.80. The company has a market cap of $77.26 billion, a P/E ratio of 14.16, a P/E/G ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company earned $5.90 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.